Colgate-Palmolive (NYSE:CL) Director John T. Cahill sold 8,000 shares of the firm’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $71.43, for a total value of $571,440.00. Following the completion of the sale, the director now directly owns 30,326 shares in the company, valued at approximately $2,166,186.18. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Shares of CL stock opened at $71.37 on Friday. The stock has a 50 day moving average of $72.54 and a two-hundred day moving average of $69.90. The company has a current ratio of 1.13, a quick ratio of 0.78 and a debt-to-equity ratio of 32.25. Colgate-Palmolive has a 12 month low of $57.41 and a 12 month high of $76.41. The company has a market capitalization of $61.51 billion, a P/E ratio of 25.15, a P/E/G ratio of 4.61 and a beta of 0.76.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.72 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. The company had revenue of $3.87 billion during the quarter, compared to the consensus estimate of $3.88 billion. During the same quarter last year, the company earned $0.77 EPS. The company’s quarterly revenue was down .5% on a year-over-year basis. Sell-side analysts predict that Colgate-Palmolive will post 2.84 earnings per share for the current fiscal year.
CL has been the topic of a number of research analyst reports. Bank of America set a $80.00 target price on Colgate-Palmolive and gave the company a “buy” rating in a report on Friday, July 12th. Piper Jaffray Companies initiated coverage on Colgate-Palmolive in a report on Tuesday. They issued an “overweight” rating on the stock. JPMorgan Chase & Co. raised Colgate-Palmolive from an “underweight” rating to a “neutral” rating and raised their target price for the company from $62.00 to $70.00 in a report on Monday, April 29th. Jefferies Financial Group raised their target price on Colgate-Palmolive from $61.00 to $73.00 and gave the company an “in-line” rating in a report on Monday, April 29th. They noted that the move was a valuation call. Finally, ValuEngine lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and six have given a buy rating to the company. Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $73.13.
Several hedge funds have recently made changes to their positions in the business. Dimensional Fund Advisors LP grew its position in Colgate-Palmolive by 3.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,737,377 shares of the company’s stock worth $103,412,000 after purchasing an additional 57,606 shares during the last quarter. Geode Capital Management LLC grew its position in Colgate-Palmolive by 7.9% during the 4th quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock worth $626,200,000 after purchasing an additional 768,550 shares during the last quarter. American National Bank purchased a new stake in shares of Colgate-Palmolive in the 1st quarter valued at $904,000. Weybosset Research & Management LLC boosted its holdings in shares of Colgate-Palmolive by 0.5% in the 1st quarter. Weybosset Research & Management LLC now owns 68,044 shares of the company’s stock valued at $4,664,000 after acquiring an additional 341 shares during the last quarter. Finally, Retirement Systems of Alabama boosted its holdings in shares of Colgate-Palmolive by 0.3% in the 1st quarter. Retirement Systems of Alabama now owns 401,234 shares of the company’s stock valued at $27,501,000 after acquiring an additional 1,068 shares during the last quarter. Institutional investors own 75.64% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Article: Why do companies engage in swaps?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.